These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19805455)

  • 1. Recombinant human hyaluronidase-enabled subcutaneous pediatric rehydration.
    Allen CH; Etzwiler LS; Miller MK; Maher G; Mace S; Hostetler MA; Smith SR; Reinhardt N; Hahn B; Harb G;
    Pediatrics; 2009 Nov; 124(5):e858-67. PubMed ID: 19805455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of recombinant human hyaluronidase-facilitated subcutaneous versus intravenous rehydration in mild to moderately dehydrated children in the emergency department.
    Spandorfer PR; Mace SE; Okada PJ; Simon HK; Allen CH; Spiro DM; Friend K; Harb G; Lebel F;
    Clin Ther; 2012 Nov; 34(11):2232-45. PubMed ID: 23062548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous rehydration: updating a traditional technique.
    Spandorfer PR
    Pediatr Emerg Care; 2011 Mar; 27(3):230-6. PubMed ID: 21378529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral versus intravenous rehydration of moderately dehydrated children: a randomized, controlled trial.
    Spandorfer PR; Alessandrini EA; Joffe MD; Localio R; Shaw KN
    Pediatrics; 2005 Feb; 115(2):295-301. PubMed ID: 15687435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Techniques for hyaluronidase-facilitated subcutaneous fluid administration with recombinant human hyaluronidase: the increased flow utilizing subcutaneously enabled administration technique (INFUSE AT) study.
    Connolly S; Korzemba H; Harb G; Lebel F; Syltevik C
    J Infus Nurs; 2011; 34(5):300-7. PubMed ID: 21915003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of recombinant human hyaluronidase-facilitated subcutaneous versus intravenous rehydration in children with mild to moderate dehydration.
    Mace SE; Harb G; Friend K; Turpin R; Armstrong EP; Lebel F
    Am J Emerg Med; 2013 Jun; 31(6):928-34. PubMed ID: 23685056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
    Dychter SS; Harrigan R; Bahn JD; Printz MA; Sugarman BJ; DeNoia E; Haughey DB; Fellows D; Maneval DC
    Clin Ther; 2014 Feb; 36(2):211-24. PubMed ID: 24486335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronidase-Assisted Resuscitation in Kenya for Severely Dehydrated Children.
    Zubairi H; Nelson BD; Tulshian P; Fredricks K; Altawil Z; Mireles S; Odongo F; Burke TF
    Pediatr Emerg Care; 2019 Oct; 35(10):692-695. PubMed ID: 28678057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The INFUSE-Morphine IIB study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneous morphine in healthy volunteers.
    Thomas JR; Yocum RC; Haller MF; Flament J
    J Pain Symptom Manage; 2009 Nov; 38(5):673-82. PubMed ID: 19819667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The INFUSE-Morphine study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneously administered morphine in patients with advanced illness.
    Thomas JR; Wallace MS; Yocum RC; Vaughn DE; Haller MF; Flament J
    J Pain Symptom Manage; 2009 Nov; 38(5):663-72. PubMed ID: 19819665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parental preference for rehydration method for children in the emergency department.
    Karpas A; Finkelstein M; Reid S
    Pediatr Emerg Care; 2009 May; 25(5):301-6. PubMed ID: 19404228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid vascular glucose uptake via enzyme-assisted subcutaneous infusion: enzyme-assisted subcutaneous infusion access study.
    Soremekun OA; Shear ML; Patel S; Kim GJ; Biddinger PD; Parry BA; Yialamas MA; Thomas SH
    Am J Emerg Med; 2009 Nov; 27(9):1072-80. PubMed ID: 19931753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous dextrose during outpatient rehydration in pediatric gastroenteritis.
    Levy JA; Bachur RG
    Acad Emerg Med; 2007 Apr; 14(4):324-30. PubMed ID: 17296801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency.
    Wasserman RL; Melamed I; Stein MR; Gupta S; Puck J; Engl W; Leibl H; McCoy B; Empson VG; Gelmont D; Schiff RI;
    J Allergy Clin Immunol; 2012 Oct; 130(4):951-7.e11. PubMed ID: 22846381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency.
    Wasserman RL; Melamed I; Stein MR; Engl W; Sharkhawy M; Leibl H; Puck J; Rubinstein A; Kobrynski L; Gupta S; Grant AJ; Ratnayake A; Richmond WG; Church J; Yel L; Gelmont D
    J Clin Immunol; 2016 Aug; 36(6):571-82. PubMed ID: 27220317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experiences with subcutaneous recombinant human hyaluronidase.
    Pirrello RD; Ting Chen C; Thomas SH
    J Palliat Med; 2007 Aug; 10(4):861-4. PubMed ID: 17803404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the role of human recombinant hyaluronidase in gravity-driven subcutaneous hydration: the INFUSE-LR study.
    Thomas JR; Yocum RC; Haller MF; von Gunten CF
    J Palliat Med; 2007 Dec; 10(6):1312-20. PubMed ID: 18095810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic-level emergency medical technician administration of fluids and glucose via enzyme-assisted subcutaneous infusion access.
    Soremekun OA; Shear ML; Connolly J; Stewart CE; Thomas SH
    Prehosp Disaster Med; 2012 Jun; 27(3):220-5. PubMed ID: 22854002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral rehydration with a plantain flour-based solution precooked with standardized electrolytes].
    Bernal C; Alcaraz GM; Botero JE
    Biomedica; 2005 Mar; 25(1):11-21. PubMed ID: 15962898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the tolerability of recombinant human hyaluronidase + normal saline and recombinant human hyaluronidase + lactated ringer's solution administered subcutaneously: A phase IV, double-blind, randomized pilot study in healthy volunteers.
    Dychter SS; Ebel D; Mead TR; Yocum RC
    Curr Ther Res Clin Exp; 2009 Dec; 70(6):421-38. PubMed ID: 24692835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.